|
1
|
Hillen F and Griffioen AW: Tumour
vascularization: sprouting angiogenesis and beyond. Cancer
Metastasis Rev. 26:489–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maniotis AJ, Folberg R, Hess A, et al:
Vascular channel formation by human melanoma cells in vivo and in
vitro: vasculogenic mimicry. Am J Pathol. 155:739–752. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El Hallani S, Boisselier B, Peglion F, et
al: A new alternative mechanism in glioblastoma vascularization:
tubular vasculogenic mimicry. Brain. 133:973–982. 2010.PubMed/NCBI
|
|
4
|
van der Schaft DW, Hillen F, Pauwels P, et
al: Tumor cell plasticity in Ewing sarcoma, an alternative
circulatory system stimulated by hypoxia. Cancer Res.
65:11520–11528. 2005.PubMed/NCBI
|
|
5
|
Shirakawa K, Kobayashi H, Heike Y, et al:
Hemodynamics in vasculogenic mimicry and angiogenesis of
inflammatory breast cancer xenograft. Cancer Res. 62:560–566.
2002.PubMed/NCBI
|
|
6
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Lin P, Han C, Cai W, Zhao X and
Sun B: Vasculogenic mimicry contributes to lymph node metastasis of
laryngeal squamous cell carcinoma. J Exp Clin Cancer Res.
29:602010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Upile T, Jerjes W, Radhi H, et al:
Vascular mimicry in cultured head and neck tumour cell lines. Head
Neck Oncol. 3:552011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin P, Wang W, Sun BC, et al: Vasculogenic
mimicry is a key prognostic factor for laryngeal squamous cell
carcinoma: a new pattern of blood supply. Chin Med J (Engl).
125:3445–3449. 2012.PubMed/NCBI
|
|
10
|
Francescone R, Scully S, Bentley B, et al:
Glioblastoma-derived tumor cells induce vasculogenic mimicry
through Flk-1 protein activation. J Biol Chem. 287:24821–24831.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shirakawa K, Wakasugi H, Heike Y, et al:
Vasculogenic mimicry and pseudo-comedo formation in breast cancer.
Int J Cancer. 99:821–828. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang HS, Feng YJ and Yao LQ: Angiogenesis,
vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J
Gynecol Cancer. 19:605–610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su M, Feng YJ, Yao LQ, et al: Plasticity
of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo.
Int J Gynecol Cancer. 18:476–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z, Li Y, Zhao W, Ma Y and Yang X:
Demonstration of vasculogenic mimicry in astrocytomas and effects
of Endostar on U251 cells. Pathol Res Pract. 207:645–651. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baeten CI, Hillen F, Pauwels P, de Bruine
AP and Baeten CG: Prognostic role of vasculogenic mimicry in
colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Warso MA, Maniotis AJ, Chen X, et al:
Prognostic significance of periodic acid-Schiff-positive patterns
in primary cutaneous melanoma. Clin Cancer Res. 7:473–477.
2001.PubMed/NCBI
|
|
18
|
Folberg R, Rummelt V, Parys-Van
Ginderdeuren R, et al: The prognostic value of tumor blood vessel
morphology in primary uveal melanoma. Ophthalmology. 100:1389–1398.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van der Schaft DW, Seftor RE, Seftor EA,
et al: Effects of angiogenesis inhibitors on vascular network
formation by human endothelial and melanoma cells. J Natl Cancer
Inst. 96:1473–1477. 2004.PubMed/NCBI
|
|
20
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eccles SA and Welch DR: Metastasis: recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Sun B, Qi L, Li H, Gao J and Leng
X: Zinc finger E-box binding homeobox 1 promotes vasculogenic
mimicry in colorectal cancer through induction of
epithelial-to-mesenchymal transition. Cancer Sci. 103:813–820.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun T, Zhao N, Zhao XL, et al: Expression
and functional significance of Twist1 in hepatocellular carcinoma:
its role in vasculogenic mimicry. Hepatology. 51:545–556. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
27
|
Shipitsin M and Polyak K: The cancer stem
cell hypothesis: in search of definitions, markers, and relevance.
Lab Invest. 88:459–463. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
30
|
Rosen JM and Jordan CT: The increasing
complexity of the cancer stem cell paradigm. Science.
324:1670–1673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ricci-Vitiani L, Pallini R, Biffoni M, et
al: Tumour vascularization via endothelial differentiation of
glioblastoma stem-like cells. Nature. 468:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang R, Chadalavada K, Wilshire J, et al:
Glioblastoma stem-like cells give rise to tumour endothelium.
Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong J, Zhao Y, Huang Q, et al: Glioma
stem/progenitor cells contribute to neovascularization via
transdifferentiation. Stem Cell Rev. 7:141–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen J, Li Y, Yu TS, et al: A restricted
cell population propagates glioblastoma growth after chemotherapy.
Nature. 488:522–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hemmati HD, Nakano I, Lazareff JA, et al:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
41
|
Fang D, Nguyen TK, Leishear K, et al: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schatton T, Murphy GF, Frank NY, et al:
Identification of cells initiating human melanomas. Nature.
451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bapat SA, Mali AM, Koppikar CB and Kurrey
NK: Stem and progenitor-like cells contribute to the aggressive
behavior of human epithelial ovarian cancer. Cancer Res.
65:3025–3029. 2005.PubMed/NCBI
|
|
45
|
Alvero AB, Chen R, Fu HH, et al: Molecular
phenotyping of human ovarian cancer stem cells unravel the
mechanisms for repair and chemo-resistance. Cell Cycle. 8:158–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hermann P, Huber S, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun S and Wang Z: Head neck squamous cell
carcinoma c-Met(+) cells display cancer stem cell properties and
are responsible for cisplatin-resistance and metastasis. Int J
Cancer. 129:2337–2348. 2011.
|
|
48
|
Monroe MM, Anderson EC, Clayburgh DR and
Wong MH: Cancer stem cells in head and neck squamous cell
carcinoma. J Oncol. 2011:7627802011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sayed SI, Dwivedi RC, Katna R, et al:
Implications of understanding cancer stem cell (CSC) biology in
head and neck squamous cell cancer. Oral Oncol. 47:237–243. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zito G, Richiusa P, Bommarito A, et al: In
vitro identification and characterization of CD133(pos) cancer
stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS
One. 3:e35442008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Prince ME and Ailles LE: Cancer stem cells
in head and neck squamous cell cancer. J Clin Oncol. 26:2871–2875.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Balic M, Lin H, Young L, et al: Most early
disseminated cancer cells detected in bone marrow of breast cancer
patients have a putative breast cancer stem cell phenotype. Clin
Cancer Res. 12:5615–5621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Charafe-Jauffret E, Ginestier C, Iovino F,
et al: Aldehyde dehydrogenase 1-positive cancer stem cells mediate
metastasis and poor clinical outcome in inflammatory breast cancer.
Clin Cancer Res. 16:45–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Davis SJ, Divi V, Owen JH, et al:
Metastatic potential of cancer stem cells in head and neck squamous
cell carcinoma. Arch Otolaryngol Head Neck Surg. 136:1260–1266.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Faber A, Barth C, Hörmann K, et al: CD44
as a stem cell marker in head and neck squamous cell carcinoma.
Oncol Rep. 26:321–326. 2011.PubMed/NCBI
|
|
58
|
Song J, Chang I, Chen Z, Kang M and Wang
CY: Characterization of side populations in HNSCC: highly invasive,
chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Goldie SJ, Mulder KW, Tan DW, Lyons SK,
Sims AH and Watt FM: FRMD4A upregulation in human squamous cell
carcinoma promotes tumor growth and metastasis and is associated
with poor prognosis. Cancer Res. 72:3424–3436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
La Fleur L, Johansson AC and Roberg K: A
CD44high/EGFRlow subpopulation within head and neck cancer cell
lines shows an epithelial-mesenchymal transition phenotype and
resistance to treatment. PLoS One. 7:e440712012.PubMed/NCBI
|
|
61
|
Tamara Marie-Egyptienne DT, Lohse I and
Hill RP: Cancer stem cells, the epithelial to mesenchymal
transition (EMT) and radioresistance: potential role of hypoxia.
Cancer Lett. Nov 28–2012.Epub ahead of print. View Article : Google Scholar
|
|
62
|
Todaro M, Alea MP, Di Stefano AB, et al:
Colon cancer stem cells dictate tumor growth and resist cell death
by production of interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Cheung ST, Cheung PF, Cheng CK, Wong NC
and Fan ST: Granulin-epithelin precursor and ATP-dependent binding
cassette (ABC)B5 regulate liver cancer cell chemoresistance.
Gastroenterology. 140:344–355. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bussolati B, Grange C, Sapino A and
Camussi G: Endothelial cell differentiation of human breast tumour
stem/progenitor cells. J Cell Mol Med. 13:309–319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hendrix MJ, Seftor EA, Meltzer PS, et al:
Expression and functional significance of VE-cadherin in aggressive
human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad
Sci USA. 98:8018–8023. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Soda Y, Marumoto T, Friedmann-Morvinski D,
et al: Transdifferentiation of glioblastoma cells into vascular
endothelial cells. Proc Natl Acad Sci USA. 108:4274–4280. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lai CY, Schwartz BE and Hsu MY: CD133+
melanoma subpopulations contribute to perivascular niche
morphogenesis and tumorigenicity through vasculogenic mimicry.
Cancer Res. 72:5111–5118. 2012.
|
|
68
|
Frank NY, Schatton T, Kim S, et al:
VEGFR-1 expressed by malignant melanoma-initiating cells is
required for tumor growth. Cancer Res. 71:1474–1485. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Dang D and Ramos DM: Identification of
αvβ6-positive stem cells in oral squamous cell carcinoma.
Anticancer Res. 29:2043–2049. 2009.
|
|
70
|
Zhang S, Guo H, Zhang D, et al:
Microcirculation patterns in different stages of melanoma growth.
Oncol Rep. 15:15–20. 2006.PubMed/NCBI
|
|
71
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Nguyen PT, Kudo Y, Yoshida M, Kamata N,
Ogawa I and Takata T: N-cadherin expression is involved in
malignant behavior of head and neck cancer in relation to
epithelial-mesenchymal transition. Histol Histopathol. 26:147–156.
2011.PubMed/NCBI
|
|
73
|
Mandal M, Myers JN, Lippman SM, et al:
Epithelial to mesenchymal transition in head and neck squamous
carcinoma: association of Src activation with E-cadherin
down-regulation, vimentin expression, and aggressive tumor
features. Cancer. 112:2088–2100. 2008. View Article : Google Scholar
|
|
74
|
Batlle E, Sancho E, Franci C, et al: The
transcription factor snail is a repressor of E-cadherin gene
expression in epithelial tumour cells. Nat Cell Biol. 2:84–89.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cano A, Pérez-Moreno MA, Rodrigo I, et al:
The transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang A, Chen G, Meng L, et al:
Antisense-Snail transfer inhibits tumor metastasis by inducing
E-cadherin expression. Anticancer Res. 28:621–628. 2008.PubMed/NCBI
|
|
77
|
Hajra KM, Chen DY and Fearon ER: The SLUG
zinc-finger protein represses E-cadherin in breast cancer. Cancer
Res. 62:1613–1618. 2002.PubMed/NCBI
|
|
78
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang J, Liang Q, Lei Y, et al: SOX4
induces epithelial-mesenchymal transition and contributes to breast
cancer progression. Cancer Res. 72:4597–4608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Eger A, Aigner K, Sonderegger S, et al:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Porsch H, Bernert B, Mehic M, Theocharis
AD, Heldin CH and Heldin P: Efficient TGFbeta-induced
epithelial-mesenchymal transition depends on hyaluronan synthase
HAS2. Oncogene. Oct 29–2012.(Epub ahead of print). View Article : Google Scholar
|
|
83
|
Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG and
Weiss SJ: Canonical Wnt signaling regulates Slug activity and links
epithelial-mesenchymal transition with epigenetic Breast Cancer 1,
Early Onset (BRCA1) repression. Proc Natl Acad Sci USA.
109:16654–16659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Guaita S, Puig I, Franci C, et al: Snail
induction of epithelial to mesenchymal transition in tumor cells is
accompanied by MUC1 repression and ZEB1 expression. J Biol Chem.
277:39209–39216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhao XL, Sun T, Che N, et al: Promotion of
hepatocellular carcinoma metastasis through matrix
metalloproteinase activation by epithelial-mesenchymal transition
regulator Twist1. J Cell Mol Med. 15:691–700. 2011. View Article : Google Scholar
|
|
86
|
Tsai JH, Donaher JL, Murphy DA, Chau S and
Yang J: Spatiotemporal regulation of epithelial-mesenchymal
transition is essential for squamous cell carcinoma metastasis.
Cancer Cell. 22:725–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Aigner K, Dampier B, Descovich L, et al:
The transcription factor ZEB1 (deltaEF1) promotes tumour cell
dedifferentiation by repressing master regulators of epithelial
polarity. Oncogene. 26:6979–6988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wellner U, Schubert J, Burk UC, et al: The
EMT-activator ZEB1 promotes tumorigenicity by repressing
stemness-inhibiting microRNAs. Nat Cell Biol. 11:1487–1495. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ahn YH, Gibbons DL, Chakravarti D, et al:
ZEB1 drives prometastatic actin cytoskeletal remodeling by
downregulating miR-34a expression. J Clin Invest. 122:3170–3183.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Sun T, Sun BC, Zhao XL, et al: Promotion
of tumor cell metastasis and vasculogenic mimicry by way of
transcription coactivation by Bcl-2 and Twist1: a study of
hepatocellular carcinoma. Hepatology. 54:1690–1706. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lirdprapamongkol K, Chiablaem K, Sila-Asna
M, Surarit R, Bunyaratvej A and Svasti J: Exploring stemness gene
expression and vasculogenic mimicry capacity in well- and
poorly-differentiated hepatocellular carcinoma cell lines. Biochem
Biophys Res Commun. 422:429–435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Passegué E, Jamieson CH, Ailles LE and
Weissman IL: Normal and leukemic hematopoiesis: are leukemias a
stem cell disorder or a reacquisition of stem cell characteristics?
Proc Natl Acad Sci USA. 100(Suppl 1): 11842–11849. 2003.
|
|
94
|
Prindull G: Hypothesis: cell plasticity,
linking embryonal stem cells to adult stem cell reservoirs and
metastatic cancer cells? Exp Hematol. 33:738–746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Notta F, Mullighan CG, Wang JC, et al:
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating
cells. Nature. 469:362–367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Biddle A, Liang X, Gammon L, et al: Cancer
stem cells in squamous cell carcinoma switch between two distinct
phenotypes that are preferentially migratory or proliferative.
Cancer Res. 71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Damonte P, Gregg JP, Borowsky AD, Keister
BA and Cardiff RD: EMT tumorigenesis in the mouse mammary gland.
Lab Invest. 87:1218–1226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Santisteban M, Reiman JM, Asiedu MK, et
al: Immune-induced epithelial to mesenchymal transition in vivo
generates breast cancer stem cells. Cancer Res. 69:2887–2895. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Fang X, Cai Y, Liu J, et al: Twist2
contributes to breast cancer progression by promoting an
epithelial-mesenchymal transition and cancer stem-like cell
self-renewal. Oncogene. 30:4707–4720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Asiedu MK, Ingle JN, Behrens MD, Radisky
DC and Knutson KL: TGFbeta/TNF(alpha)-mediated
epithelial-mesenchymal transition generates breast cancer stem
cells with a claudin-low phenotype. Cancer Res. 71:4707–4719. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Ryu HS, Park do J, Kim HH, Kim WH and Lee
HS: Combination of epithelial-mesenchymal transition and cancer
stem cell-like phenotypes has independent prognostic value in
gastric cancer. Hum Pathol. 43:520–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sarkar D, Shields B, Davies ML, Muller J
and Wakeman JA: BRACHYURY confers cancer stem cell characteristics
on colorectal cancer cells. Int J Cancer. 130:328–337. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Xia H, Cheung WK, Sze J, et al: miR-200a
regulates epithelial-mesenchymal to stem-like transition via ZEB2
and beta-catenin signaling. J Biol Chem. 285:36995–37004. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Chen YC, Chen YW, Hsu HS, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chen YS, Wu MJ, Huang CY, et al: CD133/Src
axis mediates tumor initiating property and epithelial-mesenchymal
transition of head and neck cancer. PLoS One. 6:e280532011.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Hendrix MJ, Seftor EA, Hess AR and Seftor
RE: Vasculogenic mimicry and tumour-cell plasticity: lessons from
melanoma. Nat Rev Cancer. 3:411–421. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Pisacane AM, Picciotto F and Risio M: CD31
and CD34 expression as immunohistochemical markers of endothelial
transdifferentiation in human cutaneous melanoma. Cell Oncol.
29:59–66. 2007.PubMed/NCBI
|
|
108
|
Garnier D, Milsom C, Magnus N, et al: Role
of the tissue factor pathway in the biology of tumor initiating
cells. Thromb Res. 125(Suppl 2): S44–S50. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Gill JG, Langer EM, Lindsley RC, Cai M,
Murphy TL and Murphy KM: Snail promotes the cell-autonomous
generation of Flk1(+) endothelial cells through the repression of
the microRNA-200 family. Stem Cells Dev. 21:167–176.
2012.PubMed/NCBI
|
|
110
|
Sun B, Zhang D, Zhang S, Zhang W, Guo H
and Zhao X: Hypoxia influences vasculogenic mimicry channel
formation and tumor invasion-related protein expression in
melanoma. Cancer Lett. 249:188–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Ma JL, Han SX, Zhu Q, et al: Role of Twist
in vasculogenic mimicry formation in hypoxic hepatocellular
carcinoma cells in vitro. Biochem Biophys Res Commun. 408:686–691.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Comito G, Calvani M, Giannoni E, et al:
HIF-1alpha stabilization by mitochondrial ROS promotes
Met-dependent invasive growth and vasculogenic mimicry in melanoma
cells. Free Radic Biol Med. 51:893–904. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Misra RM, Bajaj MS and Kale VP:
Vasculogenic Mimicry of HT1080 Tumour Cells In Vivo: Critical Role
of HIF-1alpha-Neuropilin-1 Axis. PLoS One. 7:e501532012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Jiang J, Tang YL and Liang XH: EMT: a new
vision of hypoxia promoting cancer progression. Cancer Biol Ther.
11:714–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bao B, Azmi AS, Ali S, et al: The
biological kinship of hypoxia with CSC and EMT and their
relationship with deregulated expression of miRNAs and tumor
aggressiveness. Biochim Biophys Acta. 1826:272–296. 2012.PubMed/NCBI
|
|
116
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Xu X and Prestwich GD: Inhibition of tumor
growth and angiogenesis by a lysophosphatidic acid antagonist in an
engineered three-dimensional lung cancer xenograft model. Cancer.
116:1739–1750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Keunen O, Johansson M, Oudin A, et al:
Anti-VEGF treatment reduces blood supply and increases tumor cell
invasion in glioblastoma. Proc Natl Acad Sci USA. 108:3749–3754.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Qu B, Guo L, Ma J and Lv Y:
Antiangiogenesis therapy might have the unintended effect of
promoting tumor metastasis by increasing an alternative circulatory
system. Med Hypotheses. 74:360–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Cao G, Fehrenbach ML, Williams JT,
Finklestein JM, Zhu JX and Delisser HM: Angiogenesis in platelet
endothelial cell adhesion molecule-1-null mice. Am J Pathol.
175:903–915. 2009. View Article : Google Scholar : PubMed/NCBI
|
